VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CME
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CMECME Group Inc.
$221.00$80.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCMEFinancials

CME Group Inc. (CME) Financials

26Y historyFree accessUpdated daily

CME demonstrates significant pricing power with gross margins consistently hovering around 86% over the last ten quarters, reflecting the scalability of its core transactional business.

CME Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00
Sales/Revenue6.76B--------------------------
Revenue Growth %---------------------------
Cost of Goods Sold0--------------------------
COGS % of Revenue---------------------------
Gross Profit5.84B5.61B5.28B4.75B4.27B3.85B4.03B3.97B3.64B3.08B3.05B2.75B2.53B2.38B2.38B2.76B2.53B2.08B2.06B1.4B789.88M625.39M483.49M489.46M429.22M361.56M0
Gross Margin %86.34%86.09%86.13%85.15%85%82.15%82.46%81.54%84.4%84.53%84.89%82.52%81.23%81.13%81.58%84.21%84.26%79.74%80.42%79.65%72.47%70.29%67.01%91.31%91.5%91.16%-
Gross Profit Growth %-6.32%11.15%11.34%10.74%-4.33%1.46%9.13%18.06%0.94%11.17%8.58%6.14%0.18%-13.93%9.15%21.48%1.16%47.24%77.09%26.3%29.35%-1.22%14.03%18.71%--
Operating Expenses1.4B1.38B1.35B1.31B1.25B1.21B1.39B1.38B1.03B745.9M824.7M756.6M760M745.1M685.8M422.9M532.5M489.1M544.48M322.25M169.03M344.25M314.69M283.33M252.85M237.72M234.63M
OpEx % of Revenue-21.23%21.99%23.56%24.91%25.75%28.46%28.38%23.89%20.47%22.94%22.74%24.42%25.38%23.53%12.89%17.73%18.72%21.26%18.35%15.51%38.69%43.61%52.86%53.9%59.93%103.57%
Selling, General & Admin150.2M150.5M132.7M144.4M137.4M151.7M191.3M174.1M166.1M117.6M144.4M215.3M225.8M208.6M203.8M203.6M192.4M165.5M141.7M137M96.25M59.79M50.41M230.32M204.34M200.08M5.22M
SG&A % of Revenue-2.31%2.16%2.59%2.74%3.23%3.92%3.58%3.85%3.23%4.02%6.47%7.25%7.1%6.99%6.21%6.41%6.33%5.53%7.8%8.83%6.72%6.99%42.97%43.56%50.44%2.3%
Research & Development0--------------------------
R&D % of Revenue---------------------------
Other Operating Expenses0--------------------------
Operating Income4.43B4.23B3.93B3.44B3.02B2.65B2.64B2.59B2.61B2.31B2.2B1.99B1.77B1.64B1.69B2.02B1.83B1.59B1.58B1.05B620.86M477.63M355.42M206.13M176.37M123.84M-8.08M
Operating Margin %65.57%64.86%64.13%61.58%60.08%56.4%54.01%53.16%60.51%63.4%61.21%59.78%56.82%55.75%58.05%61.61%60.96%60.82%61.78%59.82%56.96%53.68%49.26%38.45%37.6%31.22%-3.57%
Operating Income Growth %-7.58%14.43%13.92%14.01%0.3%1.92%-0.76%12.85%5%10.65%12.46%8.03%-3.25%-16.28%10.38%15.23%0.44%50.62%69.2%29.99%34.38%72.43%16.87%42.42%1632.13%-
EBITDA4.65B4.5B4.27B3.79B3.38B3.03B3.1B4.87B4.37B3.64B3.69B2.12B1.9B1.77B1.83B2.15B1.96B1.72B1.72B1.16B693.64M545.85M412.35M259.14M224.88M161.48M25.41M
EBITDA Margin %68.82%69.08%69.63%67.9%67.31%64.62%63.51%100%101.45%100%102.66%63.66%61.08%60.35%62.75%65.52%65.29%65.65%67.14%65.84%63.64%61.35%57.15%48.34%47.94%40.71%11.21%
EBITDA Growth %5.37%5.53%12.67%12.13%11.48%-2.3%-36.28%11.35%19.95%-1.25%74.27%11.41%7.27%-3.11%-14.92%9.62%14.32%-0.24%48.73%66.68%27.08%32.38%59.12%15.24%39.26%535.6%-
D&A (Non-Cash Add-back)219.7M275M336.8M352.6M362.6M385.4M464.4M2.28B1.76B1.33B1.49B129.2M132.6M135.1M136.9M128.5M129.9M126.3M137.34M105.65M72.78M68.22M56.93M53.02M48.51M37.64M33.49M
EBIT5.47B5.45B4.7B4.31B3.65B3.54B2.89B2.87B2.94B2.64B2.41B2.07B1.89B1.75B1.83B2.05B1.86B1.57B1.36B1.08B620.86M477.63M355.42M206.13M176.37M123.84M-8.08M
Net Interest Income1.65B-129.7M-160.9M-159.4M-162.7M-166.9M-166.2M-178M-157.7M-117M-123.5M-117.4M-119.4M-151.4M-132.2M-116.9M-140.3M-131.2M-69.9M00000000
Interest Income1.78B00000000000000002.8M38.3M00000000
Interest Expense131.6M129.7M160.9M159.4M162.7M166.9M166.2M178M157.7M117M123.5M117.4M119.4M151.4M132.2M116.9M140.3M134M108.2M00000000
Other Income/Expense0--------------------------
Pretax Income5.6B5.33B4.54B4.15B3.49B3.37B2.72B2.69B2.78B2.53B2.29B1.96B1.77B1.6B1.69B1.94B1.72B1.44B1.25B1.1B671.66M508.38M367.66M206.13M154.23M114.36M-8.08M
Pretax Margin %82.81%81.75%74.08%74.45%69.54%71.94%55.74%55.25%64.46%69.31%63.63%58.82%56.91%54.52%58.1%59.03%57.33%55.02%48.73%62.4%61.62%57.14%50.95%38.45%32.88%28.83%-3.57%
Income Tax1.34B1.27B1.02B927.4M799.3M736.7M615.7M573.8M814.1M-1.54B753.5M709.8M644.5M622.9M786.7M122.1M769.8M611.7M532.48M437.27M264.31M201.52M148.1M83.99M60.16M46.06M-3.34M
Effective Tax Rate %23.96%23.89%22.36%22.33%22.9%21.84%22.62%21.33%29.31%-60.84%32.94%36.27%36.38%38.91%46.46%6.31%44.71%42.55%42.67%39.9%39.35%39.64%40.28%40.75%39.01%40.28%41.31%
Net Income4.24B4.04B3.53B3.23B2.69B2.64B2.11B2.12B1.96B4.06B1.53B1.25B1.13B976.8M896.3M1.81B951.4M825.8M715.49M658.53M407.35M306.86M219.56M122.13M94.07M68.3M-5.91M
Net Margin %62.77%62.02%57.52%57.83%53.61%56.22%43.11%43.48%45.53%111.49%42.67%37.48%36.21%33.27%30.75%55.24%31.67%31.61%27.94%37.5%37.37%34.49%30.43%22.78%20.05%17.22%-2.61%
Net Income Growth %16.98%14.71%9.29%19.89%2.07%25.23%-0.53%7.86%-51.71%164.87%23.02%10.64%15.39%8.98%-50.54%90.49%15.21%15.42%8.65%61.66%32.75%39.76%79.77%29.84%37.72%1255.9%-
Net Income (Continuing)4.26B4.06B3.53B3.23B2.69B2.64B2.11B2.12B1.96B4.06B1.53B1.25B1.13B978.1M906.7M1.81B952.1M825.8M715.49M658.53M407.35M306.86M219.56M122.13M94.07M68.3M-5.91M
Discontinued Operations000000000000000000000000000
Minority Interest00000031.6M30.4M46.8M00005.7M86.6M70.3M68.1M0000000000
EPS (Diluted)11.6811.169.678.867.407.295.875.915.7111.944.533.693.352.922.705.432.862.482.432.992.321.761.280.720.630.47-0.04
EPS Growth %17.91%15.41%9.14%19.73%1.51%24.19%-0.68%3.5%-52.18%163.58%22.76%10.15%14.73%8.15%-50.28%89.86%15.32%2.06%-18.73%28.88%31.82%37.5%77.78%14.29%34.04%1243.55%-
EPS (Basic)-11.189.698.877.417.305.885.935.7312.004.553.713.372.942.715.452.872.492.443.012.351.791.310.750.650.47-0.04
Diluted Shares Outstanding363.21M360.23M359.94M359.5M359.18M358.93M358.52M358.24M343.74M340.23M338.97M337.89M336.06M334.4M332.32M333.81M332.48M332.74M294.83M220.53M175.62M174.19M172.05M169.67M150.3M146.37M143.87M
Basic Shares Outstanding359.32M359.63M359.39M359.02M358.71M358.34M357.76M357.15M342.34M338.71M337.5M336.22M334.41M332.68M331.25M332.74M331.5M331.83M293.69M218.77M173.48M171.57M167.72M163.46M145.33M143.87M143.87M
Dividend Payout Ratio-97.25%101.66%100.29%97.86%83.04%100.23%80.13%109.57%49.06%116.5%107.73%132.8%61.33%136.59%20.57%32.09%37.01%85.98%23.02%21.49%20.62%15.97%16.89%18.38%--

Key Metrics

Growth RegimeStable
ProfitabilityStrong
Balance SheetHealthy
Cash FlowRobust
Top Statement Risk

Competitive Treasury clearing encroachment

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Structural Dominance Sustains High Margins

As reported in financial statements, CME maintains a robust gross margin profile, consistently hovering around 86% over the last ten quarters, which underscores the significant pricing power and operational efficiency inherent in its vertically integrated clearinghouse model compared to broader exchange peers like Nasdaq or Cboe.

The stability of these margins suggests that the company successfully retains its pricing power despite the commoditized nature of electronic trading. Investors should monitor whether future competitive pressures from new entrants force a structural reduction in the rate per contract, which could threaten this high-margin baseline.

Operating Leverage Drives Scalable Profitability

Based on recent SEC filings, CME demonstrates exceptional operating leverage, with operating margins reaching 69.7% in 2026Q1, as the company effectively manages its fixed-cost infrastructure while scaling transaction volumes across its core interest rate and commodity product suites without proportional increases in overhead expenses.

The ability to expand operating margins during periods of high volume suggests that the incremental cost of processing additional trades remains negligible. This operational profile implies that the company is well-positioned to capture significant bottom-line growth if market volatility continues to drive elevated trading activity.

Earnings Quality Supported by Scale

According to reported figures, CME's net income has shown consistent resilience, with net margins frequently exceeding 57% and reaching a peak of 70.8% in 2025Q4, indicating that the company's profitability is largely driven by core transactional activity rather than non-operating items or tax anomalies.

While stock-based compensation remains a recurring expense, its impact appears relatively contained relative to the company's massive revenue base. The consistency of these earnings suggests a high-quality business model that is less susceptible to the accounting volatility often seen in more capital-intensive financial services firms.

Competitive Risks to Monopoly Moat

As highlighted in recent market developments, the emergence of the FMX Futures Exchange and potential SEC-mandated clearing changes pose a credible threat to CME's long-standing monopoly in U.S. Treasury futures, which may eventually erode the cross-margining efficiencies that currently underpin the company's structural competitive advantage.

Short-sellers may focus on the potential for these regulatory and competitive shifts to decouple execution from clearing, which would fundamentally alter the company's revenue capture. Investors should remain cautious regarding the long-term durability of the current rate per contract if these new market entrants gain meaningful liquidity traction.

CME — Frequently Asked Questions

Quick answers to the most common questions about buying CME stock.

Is CME Group Inc. (CME) profitable?

CME Group Inc. (CME) is profitable, generating $4.04B in net income for the fiscal year ending 2025 with a net profit margin of 62.0%.

What is CME Group Inc.'s operating profit margin?

CME Group Inc. (CME) reported an operating income of $4.23B, resulting in an operating profit margin of 64.9%. This margin reflects the operational efficiency of the business before interest and taxes.

What is CME Group Inc.'s gross profit and gross margin?

CME Group Inc. (CME) generated $5.61B in gross profit for the year, representing a gross profit margin of 86.1%. This demonstrates the company's core pricing power and production efficiency.